Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis
Crossref DOI link: https://doi.org/10.1007/s12029-024-01135-2
Published Online: 2024-10-31
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Karaoğlan, Beliz Bahar
Öztürk, İremsu
Akyol, Cihangir
Savaş, Berna
Utkan, Güngör
Text and Data Mining valid from 2024-10-31
Version of Record valid from 2024-10-31
Article History
Accepted: 27 October 2024
First Online: 31 October 2024
Declarations
:
: The authors declare no competing interests.